Daily GLP-1 pill effective for diabetes and obesity, Eli Lilly says
A daily pill from drugmaker Eli Lilly has shown similar effectiveness at helping people reduce blood sugar levels and lose weight compared to leading injectable GLP-1 drugs Mounjaro and Ozempic, the company announced. The once-daily pill, called orforglipron, helped patients with Type 2 diabetes during late-stage trials and has shown comparable safety results to the…
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
.png?Expires=1838763821&Key-Pair-Id=K2ZIVPTIP2VGHC&Signature=IO0~CT3pU-TcxGc~yoZSmoQx23MZVuK-~4jSii~NKEblRmyO3el7NXPu~Rh1o23voASg7hlcHLw4kvQuDK1jssEhcjoNBBvEpZ~GGOAU6yosBhpHpeF179F~h7i6VxmsBNh9gtTutkoqY73O2YCFey~IAqSzKbBqETP1kP9cAg1916Z1YkJJs-5MliMrkZ5d7-mWGLbpHp2wGj2VlMph8XzYlL4~y1O7fB~JdIS~Rs4RMRs2x0WT1qUIpHAsf3GdwtOyAmKFSpIg8xCyNGZZ5h~13nXlmpd7uPvW8tBfttpG9pFTqcway-uch5WyfHOEfi7UlJCOWrr6fCYY5PMgSg__)
